通过集成的分子对接,一个SVM算法和分子动力学模拟方法,重新利用FDA批准的药物用于牛皮的指示
Saumya Choudhary1, Noor Saba Khan2, Pallavi Saxena2
1ICMR-National Institute of Pathology, New Delhi, India. saumyachoudhary.biotech@gmail.com.
Scientific reports
|July 2, 2025
概括
药物重定向为新型牛皮治疗提供了一个有希望的策略. 这项研究确定了皮奥格利塔,三胺和狄米丁丁作为潜在的抗牛皮药物,解决了当前治疗方法的局限性.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 牛皮病的病因尚不清楚,缺乏永久缓解的治疗方法.
- 目前的生物药物昂贵,并带有风险,包括严重的感染和结核病和心血管疾病的禁忌.
研究的目的:
- 通过药物重新定位,识别FDA批准的药物作为潜在的牛皮治疗的新方法.
- 探索牛皮管理的替代治疗策略.
主要方法:
- 药物向相互作用是从自身免疫,心血管,传染病,肺部和情绪障碍的公共数据库中编制的.
- 分子对接,基因本体学 (GO) 映射,NBI评分和一个支持矢量机 (SVM) 算法用于药物优先级和验证.
- 对顶级药物标候选人进行了分子动力学模拟.
主要成果:
- 皮奥格利塔,三胺和狄米丁丁被确定为治疗牛皮的前三大候选药物.
- 该研究分析了药物向相互作用,并使用计算方法验证了潜在的候选人.
结论:
- 皮奥格利塔,特里米普拉和狄米丁丁是治疗牛皮的新疗法.
- 药物重新定位是一种可行的策略,以发现具有成本效益和潜在的更安全的牛皮治疗方法.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.2K
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
374
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
01:26Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K